Literature DB >> 15194244

Use of ethanol locks to prevent recurrent central line sepsis.

Sarah C L Metcalf1, Stephen T Chambers, Alan D Pithie.   

Abstract

Catheter-related sepsis (CRS) is a common complication of long-term parenteral nutrition. Conventional antibiotic therapy is often effective in the short-term but, because of poor activity against intraluminal microbial biofilms, may not prevent relapse. Ethanol is an effective antiseptic. We describe a case of a patient with recurrent CRS successfully treated with 70% ethanol locks.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194244     DOI: 10.1016/j.jinf.2003.08.010

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  15 in total

1.  Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failure.

Authors:  Brian A Jones; Melissa A Hull; Denise S Richardson; David Zurakowski; Kathleen Gura; Shimae C Fitzgibbons; Debora Duro; Clifford W Lo; Christopher Duggan; Tom Jaksic
Journal:  J Pediatr Surg       Date:  2010-06       Impact factor: 2.545

2.  Comparative in vitro efficacies of various catheter lock solutions.

Authors:  Robert J Sherertz; Michael S Boger; Casey A Collins; Lori Mason; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

3.  Central venous port systems as an integral part of chemotherapy.

Authors:  Ulf K Teichgräber; Robert Pfitzmann; Herbert A F Hofmann
Journal:  Dtsch Arztebl Int       Date:  2011-03-04       Impact factor: 5.594

4.  Sanitizing Effect of Ethanol Against Biofilms Formed by Three Gram-Negative Pathogenic Bacteria.

Authors:  Han-Saem Park; Youngseok Ham; Keum Shin; Yeong-Suk Kim; Tae-Jong Kim
Journal:  Curr Microbiol       Date:  2015-05-05       Impact factor: 2.188

5.  Ethanol Lock Therapy Markedly Reduces Catheter-Related Blood Stream Infections in Adults Requiring Home Parenteral Nutrition: A Retrospective Study From a Tertiary Medical Center.

Authors:  Kursat Gundogan; Nisha J Dave; Daniel P Griffith; Vivian M Zhao; Therese A McNally; Kirk A Easley; Carla I Haack; John R Galloway; Thomas R Ziegler
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-08-27       Impact factor: 4.016

Review 6.  Innovative parenteral and enteral nutrition therapy for intestinal failure.

Authors:  Hau D Le; Erica M Fallon; Vincent E de Meijer; Alpin D Malkan; Mark Puder; Kathleen M Gura
Journal:  Semin Pediatr Surg       Date:  2010-02       Impact factor: 2.754

7.  Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial.

Authors:  Lennert Slobbe; Jeanette K Doorduijn; Pieternella J Lugtenburg; Abdelilah El Barzouhi; Eric Boersma; Willem B van Leeuwen; Bart J A Rijnders
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

8.  Systematic Review and Meta-Analysis of the Utilization of Ethanol Locks in Pediatric Patients With Intestinal Failure.

Authors:  Riad Rahhal; Maisam A Abu-El-Haija; Lin Fei; Dawn Ebach; Sarah Orkin; Elizabeth Kiscaden; Conrad R Cole
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-12-19       Impact factor: 4.016

9.  Ethanol causes protein precipitation--new safety issues for catheter locking techniques.

Authors:  Gernot Schilcher; Axel Schlagenhauf; Daniel Schneditz; Hubert Scharnagl; Werner Ribitsch; Robert Krause; Alexander R Rosenkranz; Tatjana Stojakovic; Joerg H Horina
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.

Authors:  Jennifer K Broom; Stacey O'Shea; Sridevi Govindarajulu; E Geoffrey Playford; Carmel M Hawley; Nicole M Isbel; Scott B Campbell; David W Mudge; Sally Carpenter; Barbara C Johnson; Neil P Underwood; David W Johnson
Journal:  BMC Nephrol       Date:  2009-08-20       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.